Acquired Haemophilia due to Factor-VIII Inhibitors Secondary to Bladder Malignancy: A Case Report

Authors

  • Shabana Shumail Hematology Department,
  • Dr. Ayesha , Junaid Oncology Department Shifa International Hospital Islamabad, Pakistan
  • Kamran Rashid Oncology Department Shifa International Hospital Islamabad, Pakistan

Keywords:

Acquired hemophilia A (AHA),, Partial Thromboplastin Time, Factor VIII

Abstract

Acquired hemophilia A (AHA) is a severe bleeding diathesis caused by the appearance of autoantibodies against
coagulation factor VIII (FVIII). Clinical features of inherited and acquired hemophilia are spontaneous as well as
posttraumatic deep muscle-joint and mucosal bleeding. 50% cases of AHA are associated with autoimmune diseases,
malignancies, medications and the postpartum period, but in the rest of the patients development of FVIII autoantibodies is
idiopathic. Unexplained prolonged activated partial thromboplastin time (APTT) without previous history of bleeding should
warrant work up for AHA. AHA secondary to bladder malignancy is rare with only three cases reported till to-date. We
report a case of an elderly male who developed acquired hemophilia secondary to bladder malignancy and presented with a
rare clinical presentation of hemarthrosis.

Downloads

Published

2018-11-20

Issue

Section

Original article

How to Cite

1.
Shumail S, Junaid DA , Rashid K. Acquired Haemophilia due to Factor-VIII Inhibitors Secondary to Bladder Malignancy: A Case Report. Int J Pathol [Internet]. 2018 Nov. 20 [cited 2024 Dec. 22];. Available from: https://jpathology.com/index.php/OJS/article/view/223

Most read articles by the same author(s)